Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 6413-6420, December 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dlugosz, A. A.
Right arrow Articles by Yuspa, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dlugosz, A. A.
Right arrow Articles by Yuspa, S. H.

Alterations in Murine Keratinocyte Differentiation Induced by Activated rasHa Genes Are Mediated by Protein Kinase C-{alpha}

Andrzej A. Dlugosz1, Christina Cheng, Erin K. Williams, Alpa G. Dharia, Mitchell F. Denning and Stuart H. Yuspa

Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892

Primary mouse keratinocytes expressing the v-rasHa oncogene (v-rasHa keratinocytes) produce squamous papillomas when grafted onto nude mice and respond abnormally to signals for terminal differentiation both in vivo and in vitro. Since protein kinase C (PKC) activators and v-rasHa induce similar phenotypic changes in cultured keratinocytes, and cellular diacylglycerol levels are constitutively elevated in ras-transformed keratinocytes, we tested whether PKC is a downstream target for oncogenic ras in this cell type. Ca2+-dependent PKC activity was increased in lysates from cultured v-rasHa keratinocytes when compared to control cells; in contrast, Ca2+-independent activity decreased. Similar to PKC activators, v-rasHa blocked Ca2+-mediated expression of the early epidermal differentiation markers keratins K1 and K10 while inducing aberrant expression of K8. Pretreatment of v-rasHa keratinocytes with bryostatin to block PKC function restored Ca2+-mediated expression of K1 and K10 and blocked abnormal expression of K8, suggesting that these responses are mediated by the PKC pathway. Furthermore, expression of K1 is restored at bryostatin doses which specifically down-modulate PKC-{alpha}, the only Ca2+-dependent PKC isozyme detected in cultured keratinocytes. In contrast to the inhibition of K1 and K10, Ca2+-induced expression of the late epidermal differentiation markers loricrin, filaggrin, and keratinocyte transglutaminase was accelerated by v-rasHa, as previously reported in normal keratinocytes treated with PKC activators. Pretreatment of v-rasHa keratinocytes with bryostatin blocked expression of late markers in these cells, and this response was correlated with down-regulation of PKC-{alpha}. The results of this study suggest that oncogenic ras alters keratinocyte differentiation by altering the function of the PKC signaling pathway, and that PKC-{alpha} is the specific isozyme involved in down-modulating expression of keratins K1 and K10 and up-regulating expression of loricrin, filaggrin, and keratinocyte transglutaminase.

1 To whom requests for reprints should be addressed, at Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, NIH, Building 37, Room 3B08, Bethesda, MD 20892. Recipient of a Thomas B. Fitzpatrick-Kao Corporation Research Award.

Received 9/ 1/94. Accepted 11/ 4/94.




This article has been cited by other articles:


Home page
Cancer Res.Home page
E. E.W. Cohen, H. Zhu, M. W. Lingen, L. E. Martin, W.-L. Kuo, E. A. Choi, M. Kocherginsky, J. S. Parker, C. H. Chung, and M. R. Rosner
A Feed-Forward Loop Involving Protein Kinase C{alpha} and MicroRNAs Regulates Tumor Cell Cycle
Cancer Res., January 1, 2009; 69(1): 65 - 74.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Li, K. Sampat, N. Hu, J. Zakari, and S. H. Yuspa
Protein Kinase C Negatively Regulates Akt Activity and Modifies UVC-induced Apoptosis in Mouse Keratinocytes
J. Biol. Chem., February 10, 2006; 281(6): 3237 - 3243.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. A. Scholl, P. A. Dumesic, and P. A. Khavari
Mek1 Alters Epidermal Growth and Differentiation
Cancer Res., September 1, 2004; 64(17): 6035 - 6040.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Cataisson, E. Joseloff, R. Murillas, A. Wang, C. Atwell, S. Torgerson, M. Gerdes, J. Subleski, J.-L. Gao, P. M. Murphy, et al.
Activation of Cutaneous Protein Kinase C{alpha} Induces Keratinocyte Apoptosis and Intraepidermal Inflammation by Independent Signaling Pathways
J. Immunol., September 1, 2003; 171(5): 2703 - 2713.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Chaturvedi, M. Cesnjaj, P. Bacon, J. Panella, D. Choubey, M. O. Diaz, and B. J. Nickoloff
Role of INK4a/Arf Locus-Encoded Senescent Checkpoints Activated in Normal and Psoriatic Keratinocytes
Am. J. Pathol., January 1, 2003; 162(1): 161 - 170.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Muller-Decker, G. Neufang, I. Berger, M. Neumann, F. Marks, and G. Furstenberger
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis
PNAS, September 17, 2002; 99(19): 12483 - 12488.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z. Wang, Y. Liu, M. Mori, and M. Kulesz-Martin
Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates
Carcinogenesis, April 1, 2002; 23(4): 635 - 643.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Mani, C. M. Rudin, K. Kunkel, J. T. Holmlund, R. S. Geary, H. L. Kindler, F. A. Dorr, and M. J. Ratain
Phase I Clinical and Pharmacokinetic Study of Protein Kinase C-{alpha} Antisense Oligonucleotide ISIS 3521 Administered in Combination with 5-Fluorouracil and Leucovorin in Patients with Advanced Cancer
Clin. Cancer Res., April 1, 2002; 8(4): 1042 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. F. Birt, E. Duysen, W. Wang, and A. Yaktine
Corticosterone Supplementation Reduced Selective Protein Kinase C Isoform Expression in the Epidermis of Adrenalectomized Mice
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. E. Rutberg, T. L. Adams, A. Glick, M. T. Bonovich, C. Vinson, and S. H. Yuspa
Activator Protein 1 Transcription Factors Are Fundamental to v-rasHa-induced Changes in Gene Expression in Neoplastic Keratinocytes
Cancer Res., November 1, 2000; 60(22): 6332 - 6338.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. Lan, C. Trempus, and S. K. Gilmour
Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice
Cancer Res., October 1, 2000; 60(20): 5696 - 5703.
[Abstract] [Full Text]


Home page
JCOHome page
J. Nemunaitis, J. T. Holmlund, M. Kraynak, D. Richards, J. Bruce, N. Ognoskie, T. J. Kwoh, R. Geary, A. Dorr, D. Von Hoff, et al.
Phase I Evaluation of ISIS 3521, an Antisense Oligodeoxynucleotide to Protein Kinase C-Alpha, in Patients With Advanced Cancer
J. Clin. Oncol., November 1, 1999; 17(11): 3586 - 3595.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. R. Yuen, J. Halsey, G. A. Fisher, J. T. Holmlund, R. S. Geary, T. J. Kwoh, A. Dorr, and B. I. Sikic
Phase I Study of an Antisense Oligonucleotide to Protein Kinase C-{{alpha}} (ISIS 3521/CGP 64128A ) in Patients with Cancer
Clin. Cancer Res., November 1, 1999; 5(11): 3357 - 3363.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Kumar and A. Holmgren
Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters
Carcinogenesis, September 1, 1999; 20(9): 1761 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H. Wang and R. Smart
Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion
J. Cell Sci., January 10, 1999; 112(20): 3497 - 3506.
[Abstract] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Matsumura, K. Nakajima, H. Wakao, S. Hattori, K. Hashimoto, H. Sugahara, T. Kato, H. Miyazaki, T. Hirano, and Y. Kanakura
Involvement of Prolonged Ras Activation in Thrombopoietin-Induced Megakaryocytic Differentiation of a Human Factor-Dependent Hematopoietic Cell Line
Mol. Cell. Biol., July 1, 1998; 18(7): 4282 - 4290.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
Extended Abstracts
Toxicol Pathol, November 1, 1997; 25(6): 674 - 696.
[PDF]


Home page
J. Biol. Chem.Home page
H. Nakagawa, T. Inomoto, and A. K. Rustgi
A CACCC Box-like cis-Regulatory Element of the Epstein-Barr Virus ED-L2 Promoter Interacts with a Novel Transcriptional Factor in Tissue-specific Squamous Epithelia
J. Biol. Chem., June 27, 1997; 272(26): 16688 - 16699.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Rosson, T. G. O'Brien, J. A. Kampherstein, Z. Szallasi, K. Bogi, P. M. Blumberg, and J. M. Mullin
Protein Kinase C-alpha Activity Modulates Transepithelial Permeability and Cell Junctions in the LLC-PK1 Epithelial Cell Line
J. Biol. Chem., June 6, 1997; 272(23): 14950 - 14953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Denning, A. A. Dlugosz, D. W. Threadgill, T. Magnuson, and S. H. Yuspa
Activation of the Epidermal Growth Factor Receptor Signal Transduction Pathway Stimulates Tyrosine Phosphorylation of Protein Kinase C [IMAGE]
J. Biol. Chem., March 8, 1996; 271(10): 5325 - 5331.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.